Judge ponders removal of lawyers behind glyphosate class action suit for possible illegal media release of classified documents

Screen Shot at AM

A federal judge [heard] arguments [on August 24] at a federal court in San Francisco over whether the lead attorneys representing farmers in their suit claiming glyphosate exposure gave them cancer should be sanctioned or replaced for releasing documents to the media that Monsanto had deemed classified. On Aug. 1, the New York Times and advocacy group U.S. Right to Know reported on documents that seemed to reveal that the company had influenced or ghost-written what were supposed to be independent reviews of the herbicide, which is sold under the Roundup brand. However, Monsanto says the documents were classified and shouldn’t have been made public.

[GLP’s profile on US Right to Know]

The court proceedings…could also influence when the case goes to a key hearing in the suit aimed at assessing whether there’s enough evidence that glyphosate exposure can cause cancer. In December, during a proceeding known as a Daubert hearing that is expected to last five days, Judge Vince Chhabria will review all the science in preparation for a potential trial. The burden will be on the farmers to prove they have data to back their cancer claims.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Morning Agriculture: Glyphosate case leaks under scrutiny (behind paywall)

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
ChatGPT-Image-Jul-17-2026-12_42_10-PM
Viewpoint: RFK, Jr. is setting up a panel to compensate people who claim they were injured by a COVID vaccine–no proof needed 
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-17-at-12.55.22-PM
Viewpoint: Is bagged salad a dangerous science experiment? Challenging an online misinformation campaign
px-Minced-beef-meat-cow-cattle
Can we trust Trump’s USDA to accurately report farm data? Beef export numbers suggest ‘no’.
ma art page image
‘It’s time to have a conversation’: Once adamantly opposed to human gene editing, UK’s The Guardian acknowledges likely benefits
Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
ChatGPT-Image-Jun-17-2026-03_29_08-PM
Viewpoint: What’s the impact of the U.S. abandoning support for global health?
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
Screenshot-2026-07-16-at-11.32.12-AM
Viewpoint: Trump appoints climate change hoax promoter to head influential government policy project
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.